Insider Transactions in Q1 2025 at Vericel Corp (VCEL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-13.14%
|
$490,000
$49.53 P/Share
|
|
Mar 03
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+11.61%
|
$180,000
$18.0 P/Share
|
|
Mar 03
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,000
-39.19%
|
$441,000
$49.53 P/Share
|
|
Mar 03
2025
|
Heidi Hagen |
SELL
Open market or private sale
|
Direct |
9,000
-23.9%
|
$441,000
$49.53 P/Share
|
|
Mar 03
2025
|
Heidi Hagen |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+19.29%
|
$27,000
$3.74 P/Share
|
|
Mar 03
2025
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-39.16%
|
$490,000
$49.52 P/Share
|
|
Mar 03
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.28%
|
$160,000
$16.66 P/Share
|
|
Feb 25
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,137
-48.53%
|
$59,124
$52.07 P/Share
|
|
Feb 25
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,669
-68.82%
|
$86,788
$52.07 P/Share
|
|
Feb 24
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-23.95%
|
$38,376
$52.33 P/Share
|
|
Feb 24
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+37.83%
|
-
|
|
Feb 24
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,331
-35.44%
|
$69,212
$52.33 P/Share
|
|
Feb 24
2025
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+44.41%
|
-
|
|
Feb 24
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,358
-5.58%
|
$70,616
$52.33 P/Share
|
|
Feb 24
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,625
+15.98%
|
-
|
|
Feb 24
2025
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,486
-13.79%
|
$129,272
$52.33 P/Share
|
|
Feb 24
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,250
+22.56%
|
-
|
|
Feb 24
2025
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,459
-3.15%
|
$439,868
$52.33 P/Share
|
|
Feb 24
2025
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,250
+6.37%
|
-
|
|
Feb 24
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
636
-0.95%
|
$33,072
$52.33 P/Share
|
|
Feb 24
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+2.22%
|
-
|
|
Feb 20
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,835
-83.53%
|
$218,595
$57.32 P/Share
|
|
Feb 19
2025
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-9.44%
|
$75,924
$57.78 P/Share
|
|
Feb 19
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+16.63%
|
-
|
|
Feb 19
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,710
-58.64%
|
$95,760
$56.72 P/Share
|
|
Feb 19
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
777
-14.47%
|
$44,289
$57.78 P/Share
|
|
Feb 19
2025
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+24.59%
|
-
|
|
Feb 19
2025
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,196
-1.65%
|
$239,172
$57.78 P/Share
|
|
Feb 19
2025
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,938
+3.39%
|
-
|
|
Feb 19
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
853
-1.32%
|
$48,621
$57.78 P/Share
|
|
Feb 19
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+2.64%
|
-
|
|
Feb 18
2025
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,389
-17.78%
|
$250,173
$57.28 P/Share
|
|
Feb 18
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,075
+26.64%
|
-
|
|
Feb 18
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,210
-16.78%
|
$68,970
$57.28 P/Share
|
|
Feb 18
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,920
+26.14%
|
-
|
|
Feb 18
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,259
-5.75%
|
$128,763
$57.28 P/Share
|
|
Feb 18
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,379
+15.62%
|
-
|
|
Feb 18
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,463
-30.15%
|
$140,391
$57.28 P/Share
|
|
Feb 18
2025
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,325
+38.87%
|
-
|
|
Feb 18
2025
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,423
-2.16%
|
$309,111
$57.28 P/Share
|
|
Feb 18
2025
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,950
+5.77%
|
-
|
|
Feb 18
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-1.54%
|
$56,145
$57.28 P/Share
|
|
Feb 18
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,325
+4.08%
|
-
|
|
Feb 12
2025
|
Kevin F Mclaughlin |
SELL
Open market or private sale
|
Direct |
7,000
-20.64%
|
$385,000
$55.45 P/Share
|
|
Feb 12
2025
|
Kevin F Mclaughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+16.15%
|
$21,000
$3.25 P/Share
|
|
Feb 07
2025
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+19.27%
|
$57,000
$3.74 P/Share
|
|
Feb 05
2025
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
2,500
-8.59%
|
$155,000
$62.5 P/Share
|
|
Feb 05
2025
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.91%
|
$32,500
$13.05 P/Share
|
|
Feb 05
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,092
-47.52%
|
$66,612
$61.99 P/Share
|
|
Feb 05
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,092
+32.21%
|
$52,416
$48.8 P/Share
|